atrasentan has been researched along with s6c sarafotoxin in 13 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (s6c sarafotoxin) | Trials (s6c sarafotoxin) | Recent Studies (post-2010) (s6c sarafotoxin) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 595 | 3 | 37 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Orléans-Juste, P; Piovezan, AP; Rae, GA; Souza, GE | 1 |
| Burke, SE; Cox, BF; Ford, TT; Fu, KI; Lubbers, NL; Nelson, RA; Padley, RJ; Wegner, CD | 1 |
| Adler, AL; Calzadilla, SV; Dayton, BD; Jae, HS; Marsh, KC; Novosad, EI; Opgenorth, TJ; von Geldern, TW; Wessale, JL; Winn, M; Wu-Wong, JR | 1 |
| Banes, AK; Chen, AF; Fink, GD; Galligan, JJ; Li, L; Watts, SW | 1 |
| Fujimori, A; Fujiyasu, N; Koakutsu, A; Miyata, K; Sasamata, M; Sato, S; Shibasaki, K; Sudoh, K; Tanahashi, M; Tanaka, S; Yuyama, H | 1 |
| Fujimori, A; Fujiyasu, N; Miyata, K; Noguchi, Y; Ohtake, A; Sasamata, M; Sato, S; Sudoh, K; Ukai, M; Yuyama, H | 1 |
| Fujimori, A; Miyata, K; Noguchi, Y; Ohtake, A; Sasamata, M; Sato, S; Sudoh, K; Ukai, M; Yuyama, H | 1 |
| Cook, AK; Imig, JD; Inscho, EW; Pollock, DM | 1 |
| Caron, A; Dupuis, J; Sauvageau, S; Thorin, E | 1 |
| Fink, G; Lau, Y; Li, M; Osborn, J; Watts, S | 1 |
| Elgebaly, MM; Ergul, A; Harris, AK; Li, W; Sachidanandam, K | 1 |
| Elgebaly, MM; Ergul, A; Harris, AK; Hutchinson, JR; Mezzetti, EM; Portik-Dobos, V; Sachidanandam, K | 1 |
| Gariepy, CE; Tykocki, NR; Watts, SW | 1 |
13 other study(ies) available for atrasentan and s6c sarafotoxin
| Article | Year |
|---|---|
Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ET(B) receptor activation.
Topics: Animals; Atrasentan; Capsaicin; Edema; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hyperalgesia; Male; Mice; Nociceptors; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Piperidines; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Viper Venoms | 2000 |
Evidence for vasoconstriction mediated by the endothelin-B receptor in domestic swine.
Topics: Angiotensin II; Animals; Animals, Domestic; Atrasentan; Blood Pressure; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Female; Femoral Artery; Protein Precursors; Pyrrolidines; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Swine; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Viper Venoms | 2000 |
Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: ex vivo and in vivo studies.
Topics: Analysis of Variance; Animals; Aorta; Atrasentan; Dogs; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Macaca fascicularis; Male; Muscle, Smooth, Vascular; Pyrrolidines; Rabbits; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Vasoconstrictor Agents; Vasodilator Agents; Viper Venoms | 2002 |
NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
Topics: Acetophenones; Allopurinol; Animals; Atrasentan; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Venae Cavae; Viper Venoms; Xanthine Oxidase | 2003 |
Effects of selective endothelin ET(A) receptor antagonists on endothelin-1-induced potentiation of cancer pain.
Topics: Analgesics, Non-Narcotic; Animals; Atrasentan; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin-1; Hindlimb; Male; Mice; Mice, SCID; Pain; Prostatic Neoplasms; Pyrimidines; Pyrrolidines; Sulfonamides; Time Factors; Viper Venoms | 2004 |
Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist.
Topics: Atrasentan; Binding, Competitive; Blood Pressure; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Humans; Iodine Radioisotopes; Oligopeptides; Peptides, Cyclic; Piperidines; Pyrimidines; Pyrrolidines; Radioligand Assay; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Time Factors; Viper Venoms | 2004 |
Pharmacological characterization of YM598, a selective endothelin-A receptor antagonist.
Topics: Administration, Oral; Animals; Atrasentan; Binding, Competitive; Biological Availability; Blood Pressure; Bosentan; Cell Line, Tumor; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Humans; Injections, Intravenous; Muscle, Smooth, Vascular; Oligopeptides; Peptides, Cyclic; Piperidines; Pyrimidines; Pyrrolidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Viper Venoms | 2004 |
ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin.
Topics: Animals; Arterioles; Atrasentan; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Endothelins; Male; Peptide Fragments; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Vasoconstriction; Viper Venoms | 2005 |
Endothelin-1-induced pulmonary vasoreactivity is regulated by ET(A) and ET(B) receptor interactions.
Topics: Animals; Atrasentan; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; In Vitro Techniques; Isometric Contraction; Lung; Male; Perfusion; Pressure; Pulmonary Artery; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Vascular Resistance; Vasoconstriction; Vasodilation; Viper Venoms | 2007 |
Chronic activation of endothelin B receptors: new model of experimental hypertension.
Topics: Animals; Atrasentan; Blood Pressure; Blood Volume; Cardiac Output; Disease Models, Animal; Diuresis; Drug Administration Schedule; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Heart Rate; Hypertension; Male; Natriuresis; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin B; Stroke Volume; Sulfonamides; Vascular Resistance; Viper Venoms | 2007 |
Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.
Topics: Acetylcholine; Animals; Atrasentan; Basilar Artery; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Male; Pyrrolidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Viper Venoms | 2008 |
Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.
Topics: Acetylcholine; Animals; Atrasentan; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Male; Mesenteric Arteries; Microcirculation; Myography; Peptides, Cyclic; Pyrrolidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Up-Regulation; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Viper Venoms | 2008 |
Endothelin ET(B) receptors in arteries and veins: multiple actions in the vein.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Atrasentan; Dinoprost; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Endothelium, Vascular; In Vitro Techniques; Male; Nitroarginine; Oligopeptides; Piperidines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Endothelin A; Receptor, Endothelin B; Tunica Intima; Tunica Media; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Venae Cavae; Viper Venoms | 2009 |